Phoenix Data Systems has made these strong gains in revenue and profitability through a combination of noteworthy customer wins and expanded relationships with existing clients
KING OF PRUSSIA, Pa. (PRWEB) December 3, 2007
Key market segments for this new business includes Top 50 pharmas, plus an international mix of smaller and mid-sized pharmaceutical and biotechnology companies. "Full Service EDC, which incorporates clinical data management, delivers functional outsourcing benefits that have helped our clients to succeed in all kinds of trials, and especially Phase III. We have started 18 pivotal Phase III studies for 9 customers this year alone," stated Stephen Boccardo, VP of Sales and Marketing. "The combination of highly functional software and our EDC regulatory submission experience has proven sensible and attractive for clients that have reached this stage of the clinical development process. Combined with the control and predictability of our business model, PDS is recognized as one the leaders for phase III pivotal studies."
Phoenix Data Systems' increase in customer engagements is illustrated in their improved financial position and backlog. PDS reports that its project backlog is growing steadily and currently exceeds $24.5 million. To accommodate near term growth, Phoenix Data Systems recently added nearly 17,000 Sq. ft. of office space in King of Prussia. In addition, PDS reports that the number of employees has increased commensurately to service the growing volume. With over 120 employees, PDS is adding people in nearly every area of operations.
"Phoenix Data Systems has made these strong gains in revenue and profitability through a combination of noteworthy customer wins and expanded relationships with existing clients," said Bill Claypool, CEO of Phoenix Data Systems. "While our core EDC business is very good, we are also extremely pleased by the continued success of our Full Service EDC approach and the rapid uptake of data management services by both new and existing clients. Our improving backlog and sales pipeline give us great reasons for optimism about 2008 and beyond."
Phoenix Data Systems also received a "positive" rating in the November 2007 Gartner* report "MarketScope for Life Science Clinical Study Automation and Management Applications." The Gartner MarketScope evaluated vendors for clinical study applications as defined by a broad range of criteria for size, global reach, and product functionality, as well as validation by Gartner's Life Science Advisory Board as a 'vendor of interest.'
About Phoenix Data Systems
Phoenix Data Systems, Inc. (PDS) is a leading eClinical technology provider, offering Full Service EDC, a unique combination of electronic data capture, interactive voice response, and clinical data management services. Full Service EDC provides clinical data managers with optimal control to run well-managed studies. The Company's flagship product, PDS Express(TM) has been deployed globally, spanning most therapeutic areas and studies of all Phases. More information is available at http://www.phoenixdatasystems.net.
- The MarketScope is copyrighted 2007 by Gartner, Inc. and is reused with permission. The MarketScope is an evaluation of a marketplace at and for a specific time period. It depicts Gartner's analysis of how certain vendors measure against criteria for that marketplace, as defined by Gartner. Gartner does not endorse any vendor, product or service depicted in the MarketScope, and does not advise technology users to select only those vendors with the highest rating. Gartner disclaims all warranties, express or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.